» Articles » PMID: 22348151

Morphological and Functional Changes in the Retina After Chronic Oxygen-induced Retinopathy

Overview
Journal PLoS One
Date 2012 Feb 21
PMID 22348151
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

The mouse model of oxygen-induced retinopathy (OIR) has been widely used for studies of retinopathy of prematurity (ROP). This disorder, characterized by abnormal vascularization of the retina, tends to occur in low birth weight neonates after exposure to high supplemental oxygen. Currently, the incidence of ROP is increasing because of increased survival of these infants due to medical progress. However, little is known about changes in the chronic phase after ROP. Therefore, in this study, we examined morphological and functional changes in the retina using a chronic OIR model. Both the a- and b-waves in the OIR model recovered in a time-dependent manner at 4 weeks (w), 6 w, and 8 w, but the oscillatory potential (OP) amplitudes remained depressed following a return to normoxic conditions. Furthermore, decrease in the thicknesses of the inner plexiform layer (IPL) and inner nuclear layer (INL) at postnatal day (P) 17, 4 w, and 8 w and hyperpermeability of blood vessels were observed in conjunction with the decrease in the expression of claudin-5 and occludin at 8 w. The chronic OIR model revealed the following: (1) a decrease in OP amplitudes, (2) morphological abnormalities in the retinal cells (limited to the IPL and INL) and blood vessels, and (3) an increase in retinal vascular permeability via the impairment of the tight junction proteins. These findings suggest that the experimental animal model used in this study is suitable for elucidating the pathogenesis of ROP and may lead to the development of potential therapeutic agents for ROP treatment.

Citing Articles

Chronic intermittent hypoxia disrupts protective microgliosis in ischemic proliferative retinopathy.

Yang T, Ronning K, Augustin S, Blond F, Nous C, Argyriou F J Neuroinflammation. 2025; 22(1):82.

PMID: 40087728 DOI: 10.1186/s12974-025-03392-9.


Animal Models of Retinopathy of Prematurity: Advances and Metabolic Regulators.

Maurya M, Liu C, Bora K, Kushwah N, Pavlovich M, Wang Z Biomedicines. 2024; 12(9).

PMID: 39335451 PMC: 11428941. DOI: 10.3390/biomedicines12091937.


Agonism of β3-Adrenoceptors Inhibits Pathological Retinal Angiogenesis in the Model of Oxygen-Induced Retinopathy.

Melecchi A, Canovai A, Amato R, Dal Monte M, Filippi L, Bagnoli P Invest Ophthalmol Vis Sci. 2024; 65(10):34.

PMID: 39186263 PMC: 11361380. DOI: 10.1167/iovs.65.10.34.


Assessment of Inner Blood-Retinal Barrier: Animal Models and Methods.

Bora K, Kushwah N, Maurya M, Pavlovich M, Wang Z, Chen J Cells. 2023; 12(20).

PMID: 37887287 PMC: 10605292. DOI: 10.3390/cells12202443.


Targeting proliferative retinopathy: Arginase 1 limits vitreoretinal neovascularization and promotes angiogenic repair.

Fouda A, Xu Z, Suwanpradid J, Rojas M, Shosha E, Lemtalsi T Cell Death Dis. 2022; 13(8):745.

PMID: 36038541 PMC: 9424300. DOI: 10.1038/s41419-022-05196-8.


References
1.
Korol S, Leuenberger P, Englert U, BABEL J . In vivo effects of glycine on retinal ultrastructure and averaged electroretinogram. Brain Res. 1975; 97(2):235-51. DOI: 10.1016/0006-8993(75)90447-3. View

2.
Nakamura S, Chikaraishi Y, Tsuruma K, Shimazawa M, Hara H . Ruboxistaurin, a PKCbeta inhibitor, inhibits retinal neovascularization via suppression of phosphorylation of ERK1/2 and Akt. Exp Eye Res. 2009; 90(1):137-45. DOI: 10.1016/j.exer.2009.09.022. View

3.
Kaur C, Foulds W, Ling E . Blood-retinal barrier in hypoxic ischaemic conditions: basic concepts, clinical features and management. Prog Retin Eye Res. 2008; 27(6):622-47. DOI: 10.1016/j.preteyeres.2008.09.003. View

4.
Miller R, Dowling J . Intracellular responses of the Müller (glial) cells of mudpuppy retina: their relation to b-wave of the electroretinogram. J Neurophysiol. 1970; 33(3):323-41. DOI: 10.1152/jn.1970.33.3.323. View

5.
Chan-Ling T, Stone J . Degeneration of astrocytes in feline retinopathy of prematurity causes failure of the blood-retinal barrier. Invest Ophthalmol Vis Sci. 1992; 33(7):2148-59. View